Expertise

Neurosurgical Critical Disease, Stroke, Intracranial Infective Disease

Research Interests

Subarachnoid Hemorrhage; Critical Care of Ischemic Cerebral Disease

Background

Dr. Yueqiao Xu is a Neurosurgical Intensive Care doctor at the Neurosurgical Critical Care Center, Department of Neurosurgery Xuanwu Hospital, Capital Medical University, China International Neuroscience Institute(CHINA-INI).  She is also an assistant professor at the Capital Medical University.

Dr. Yueqiao Xu graduated from Jilin University with master degrees in medical science and MD from Capital Medical University for Neurosurgey. She received her medical training at Department of Neurosurgery Xuanwu Hospital, Capital Medical University.  

Dr. Yueqiao Xu studies ways to treat Subarachnoid Hemorrhage and Critical Care of Ischemic Cerebral Disease. She has advanced neurocritical care training from Ronald Regan Hospital, UCLA Medical Center 2008-2009.

Education 

MD, Capital Medical University (2008) 

Certifications

China Board of Surgrey (2003)

China Board of Neurosurgery (2014)

Research & Publications

1. Yueqiao Xu, Meng Qi, et al. The effect of remote ischemic conditioning on blood coagulation function and cerebral blood flow in patients with aneurysmal subarachnoid hemorrhage. Neurological sciences 2020 Feb;41(2):335-340 doi:10.1007/s10072-019-04057-1.

2. Wang T, Xu Y#, et al. Effect of Remote Ischemic conditioning in patients with Takotsubo Syndrome after acute stroke: study protocol for a randomised controlled trial. Frontiers in Neurology stroke. 2020,11,286.doi:10.3389/fneur:2020.00286

3. Zhi Liu, Yueqiao Xu, Yungao Wan, Jing Gao, Yanyan Chu, Jing Li. Exosomes from adipose-derived mesenchymal stem cells prevent cardiomyocyte apoptosis induced by oxidative stress. Cell death discovery 2019;5:79 doi:10.1038/s41420-019-0159-5

4. Shang F#, Xu Y#,*, Wang N, Cheng W, Chen W, Duan W.Diagnosis and treatment of severe neurosurgical patients with pyogenic ventriculitis caused by gram-negative bacteria.  Neurol Sci. 2018;39(1):79-84.  （2016 1.749）   

5. Liu Z#, Xu Y#, Hao H, Yin C, Xu J, Li J, Wang Y, Xu D*. Efficacy of high intensity atorvastatin versus moderate intensity atorvastatin for acute coronary syndrome patients with diabetes mellitus. Int J Cardiol. 2016 ;222:22-6.  （2016 6.189）

Professional Memberships

Chinese Neurosurgery Association 

Chinese Stroke Association, Cerebral Vascular Disease Group